Company Filing History:
Years Active: 1994-1996
Title: The Innovative Mind of J John Cohen
Introduction
J John Cohen is a notable inventor based in Denver, Colorado, who has made significant contributions to the field of biotechnology. With a focus on programmed cell death in mammalian cells, Cohen has been granted two patents that highlight his innovative approach towards understanding and manipulating biological processes.
Latest Patents
Cohen's latest patents delve into DNA sequences that encode proteins essential for eliciting and detecting programmed polypeptides and mutants associated with programmed cell death in mammalian cells. The patents also encompass methods for detecting this vital process, as well as activating programmed cell death in unwanted mammalian cells. Additionally, he has developed methods aimed at preventing unwanted cell death that occurs in degenerative disorders, showcasing his commitment to advancing medical science through innovation.
Career Highlights
Throughout his career, Cohen has been associated with esteemed institutions such as the University of Colorado Foundation, Inc. and the University of Colorado. His roles in these institutions have allowed him to collaborate with various experts and contribute to groundbreaking research in his field.
Collaborations
Cohen has had the opportunity to work alongside accomplished professionals like Gregory P. Owens and William E. Hahn, enhancing the collaborative nature of his research efforts. These partnerships have fostered an environment where innovative ideas can thrive, further advancing the understanding of programmed cell death and its implications.
Conclusion
Through his pioneering patents and collaborations, J John Cohen has established himself as an influential figure in biotechnology. His work offers valuable insights into programmed cell death, presenting potential therapeutic avenues for addressing degenerative diseases in mammals. As an inventor, Cohen continues to pave the way for future innovations in the field.